— Know what they know.
Not Investment Advice
Also trades as: CURA.TO (TSX) · $vol 3M · CURA.CN (CNQ) · $vol 2M

CURLF OTC

Curaleaf Holdings, Inc.
1W: -10.1% 1M: -0.5% 3M: +4.7% YTD: +26.6% 1Y: +14.0% 3Y: -25.5% 5Y: -73.0%
$9.95
-0.33 (-3.24%)
 
Weekly Expected Move ±8.5%
$8 $9 $10 $11 $12
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 52 · $2.6B mcap · 169M float · 0.169% daily turnover · Short 34% of daily vol

Income Trends

Revenue
$1.3B +0.9% ▲
5Y CAGR: +14.4%
Gross Profit
$498M +12.0% ▲
5Y CAGR: +34.9%
Operating Income
$26M +34.7% ▲
Net Income
-$235M -3.7% ▼
EPS (Diluted)
$-0.31 -6.9% ▼
EBITDA
$167M -24.8% ▼
5Y CAGR: -2.5%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$1.2B$1.2B$1.4B$1.3B$1.3B
YoY Growth+79.7%+3.3%+12.0%-6.8%+0.9%
Cost of Revenue$705M$732M$885M$833M$792M
Gross Profit$480M$493M$486M$445M$498M
Gross Margin40.5%40.2%35.5%34.8%38.6%
R&D Expenses$0$0$0$0$0
SG&A Expenses$422M$430M$443M$426M$472M
Operating Expenses$422M$430M$443M$426M$472M
Operating Income$58M$62M$44M$19M$26M
Operating Margin4.9%5.1%3.2%1.5%2.0%
Interest Expense$79M$89M$100M$101M$103M
Income Before Tax-$62M-$83M-$127M-$112M-$80M
Tax Expense$151M$172M$117M$94M$126M
Net Income-$204M-$355M-$286M-$227M-$235M
Net Margin-17.2%-29.0%-20.9%-17.7%-18.2%
EPS (Diluted)$-0.16$-0.53$-0.40$-0.29$-0.31
EBITDA$149M$161M$191M$222M$167M
Shares Outstanding699M711M724M741M762M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms